Detalles de la búsqueda
1.
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
BMC Gastroenterol
; 22(1): 199, 2022 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35448949
2.
Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).
Gastroenterol Hepatol
; 45(7): 499-506, 2022.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-34634427
3.
Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough.
Clin Colon Rectal Surg
; 35(1): 32-43, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069028
4.
Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.
Clin Gastroenterol Hepatol
; 18(2): 304-312, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31252191
5.
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
Med Sci Monit
; 20: 487-98, 2014 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24667275
6.
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.
Therap Adv Gastroenterol
; 16: 17562848231210053, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026104
7.
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial.
Biomedicines
; 11(6)2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371853
8.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Arq Gastroenterol
; 59(suppl 1): 51-84, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995889
9.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Arq Gastroenterol
; 59(suppl 1): 20-50, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995888
10.
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
World J Gastroenterol
; 27(11): 1022-1042, 2021 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33776370
11.
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey.
World J Gastroenterol
; 27(12): 1226-1239, 2021 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33828396
12.
Performance of two commercial ELISAs for detecting IgA anti-human and anti-guinea pig tissue transglutaminase antibodies.
Clin Lab
; 56(1-2): 29-35, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20380357
13.
Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.
Clinics (Sao Paulo)
; 75: e1909, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321117
14.
Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
Inflamm Intest Dis
; 5(2): 93-97, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32984404
15.
BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
Arq Gastroenterol
; 56(3): 318-322, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633732
16.
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
World J Gastroenterol
; 25(9): 1142-1157, 2019 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863001
17.
Ulcerative colitis - treatment with biologicals.
Rev Assoc Med Bras (1992)
; 65(4): 547-553, 2019 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31066808
18.
VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY.
Arq Gastroenterol
; 56(3): 312-317, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633731
19.
TOFACITINIB IN THE MANAGEMENT OF ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF AND ANTI-INTEGRIN THERAPIES.
Arq Gastroenterol
; 55(2): 198-200, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30043874
20.
ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY.
Arq Gastroenterol
; 54(4): 321-327, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977114